Stock listing
Research Alliance Corporation Iii
Selected listing: RACC · NASDAQ · USD · US
Research Alliance Corporation Iii (NASDAQ:RACC), Finance. Latest release Jul 27, 2026: Oak Hill Bio and Research Alliance Corporation III Announce Business…
- Ticker
- NASDAQ:RACC
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Research Alliance Corporation Iii
The company focuses on strategic investments and partnerships within its sector. RACC aims to leverage its resources and expertise to drive growth and innovation in its operations.
Latest news from Research Alliance Corporation Iii
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome
July 27, 2026
Research Alliance Corp III: Net income $(65,249), EPS $(0.06) — 10-Q Summary
July 2, 2026
Research Alliance Holdings III LLC Discloses Investment at Research Alliance Corporation III with 14.7% Stake
May 29, 2026
Research Alliance Corp III prices IPO for $75M, deposits $75M in trust
May 28, 2026
Research Alliance III Closes $75 Million IPO; Sets Trust And $2.75 Million Sponsor Private Placement
May 21, 2026
Research Research Alliance Corporation Iii
Research Alliance Corporation Iii company profile
View the public company page for Research Alliance Corporation Iii on 6ix.
Research Alliance Corporation Iii news
Read company news and market updates connected to Research Alliance Corporation Iii.
Research Alliance Corporation Iii investor events
Find investor webinars, events, and replay context for Research Alliance Corporation Iii.